-
1 Comment
Pro-Dex, Inc is currently in a long term downtrend where the price is trading 3.7% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.1.
Pro-Dex, Inc's total revenue rose by 3.8% to $8M since the same quarter in the previous year.
Its net income has dropped by 73.0% to $337K since the same quarter in the previous year.
Finally, its free cash flow fell by 445.8% to $-5M since the same quarter in the previous year.
Based on the above factors, Pro-Dex, Inc gets an overall score of 2/5.
| CurrencyCode | USD |
|---|---|
| ISIN | US74265M2052 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Exchange | NASDAQ |
| Beta | 0.98 |
|---|---|
| Dividend Yield | 0.0% |
| Target Price | 26 |
| PE Ratio | 16.3 |
| Market Cap | 58M |
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for PDEX using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
